Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...

Although it has been plagued by multiple issues, including falling sales with lower demand for its Covid-19 products, and an ...

The pill had already received a mixed reception from physicians. A legal battle between Pfizer and Moderna over their rival ...

Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...

Pfizer has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the ...

The at-home test kits are designed to detect current COVID-19 variants, and can be used through the end of this year.

Currently, the KP.3 and KP.3.1.1 FLiRT variants, derivatives of KP.1 and KP.2, are the most prevalent in Canada and the ...

Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada ...

That includes vaccines for flu, RSV (for babies and the elderly) and, for anyone six months or older, COVID-19. While the new ...

Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine ...

The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the ...